Your shopping cart is currently empty

STX-107 is a potent and selective mGluR5 agonist for the study of Fragile X Syndrome.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $390 | - | In Stock | |
| 5 mg | $850 | - | In Stock | |
| 10 mg | $1,280 | - | In Stock | |
| 25 mg | $2,170 | - | In Stock | |
| 50 mg | $3,260 | - | In Stock |
| Description | STX-107 is a potent and selective mGluR5 agonist for the study of Fragile X Syndrome. |
| In vitro | Treatment of hippocampal neuron cultures with STX-107 (1 μM for 24 hours) significantly inhibited excessive mGluR5-mediated signaling and restored dendritic spine density and synaptic protein levels in FMR1-deficient mouse neurons, indicating its ability to modulate synaptic plasticity in vitro[1]. |
| In vivo | In Fmr1 knockout mice, intraperitoneal injection of STX-107 (10 mg/kg once daily for 7 days) significantly reduced autism-like hyperactivity and excessive exploratory behavior. The compound also partially restored deficits in social interaction and abnormal startle response, demonstrating its potential to ameliorate behavioral phenotypes in vivo[1]. |
| Synonyms | STX107, STX 107 |
| Molecular Weight | 319.36 |
| Formula | C18H10FN3S |
| Cas No. | 935685-90-8 |
| Smiles | N#CC1=CC(F)=CC(=C1)C2=NC=C(C#CC=3N=C(SC3)C)C=C2 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.